Trials / Completed
CompletedNCT03225404
Effectiveness of Percutaneous Electrolysis in the Treatment of Lateral Epicondylalgia. A Single-Blind Randomized Controlled Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- University of Cadiz · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The concept of epicondylitis refers to the manifestation of pain ni the area of insertation of the epicondile muscles, and that it is accompained by limitation funcional.A tendinopathy is characterized as a process of degenaration, with fibroblast proliferation and disorganization of the fibers of collagen. This tendon pathology especially affects the epicondyle extensors and especially the first and second radial and short extensor carpal.
Detailed description
Eccentric exercises of the epicondyle muscles were performed in 3 sets of 10 repetitions. Participants were asked to perform the exercise program on an individual basis twice every day for 4 weeks. The eccentric program consisted of 3 exercises, focusing on the epicondyle muscles. Participants were asked to do a normal flexion extension (concentric phase) and a slow return to the initial position (eccentric phase) included first the concentric phase, and the eccentric phase was slowly conducted. The exercise program was taught by a physiotherapist in the first session and monitored in the subsequent sessions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Epte group | Therapeutic Percutaneous Electrolysis once week for four weeks associated with eccentric exercises devices at home. |
| OTHER | Dry needling group | The intervention for this group consisted of dry needling in trigger points associated with eccentric exercises devices at home. |
Timeline
- Start date
- 2018-07-18
- Primary completion
- 2018-08-18
- Completion
- 2018-09-18
- First posted
- 2017-07-21
- Last updated
- 2022-03-04
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03225404. Inclusion in this directory is not an endorsement.